Technical Signal Analysis for Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - The Oracle Examiner
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)'s stock fluctuated in the range of $15.90 and $16.39 during the previous active session. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) traded with the volume of 766679 with average volume of 846.3 Million.
Which Way Traders Signposts Celgene Corporation (CELG), Intra-Cellular Therapies, Inc. (ITCI) Stocks? - StockNewsJournal
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), stock is trading $42.40 above the 52-week high and has displayed a high EPS growth of -59.00% in last 5 years. The 1 year EPS growth rate is 7.30%. Its share price has risen 32.22% in three months and is ...
Intra-Cellular Therapies Inc (ITCI) EPS Estimated At $-0.53 - BZ Weekly
After posting $-0.41 EPS for the previous quarter, Intra-Cellular Therapies Inc's analysts now forecast 29.27 % negative EPS growth. The stock decreased 1.77% or $0.29 on October 13, reaching $16.09. About 547,969 shares traded. Intra-Cellular ...
Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Experiences Heavy ... - HugoPress
Trading volume for Intra-Cellular Therapies Inc. was 1306K in the last trading session. Volume was up 213.95% over the stocks average daily volume. Investors.
Technical Facts to Know: Intra-Cellular Therapies, Inc. (ITCI) traded -29.01% away from 52-Week High - Voice Of Analysts
Illumina, Inc. (ILMN) stock price is at a -3.57% downfall to its 52-week high and above 73.15% to a 52-week low. Analysts assigned mean rating at 2.40 (1.0 = Strong Buy, 5.0 = Sell). The trailing P/E is at 40.73. It trades with a Forward P/E valuation ...altro »
Intra-Cellular Therapies, Inc. (ITCI): Scrutinizing the Chart - Economic News
If, for instance, a stock's volumes suddenly increase by a significant amount, it's usually a sign that the level of conviction behind the trade is high. Investors may feel very strongly about the future direction of the stock in question. Intra ...
Analysts Layout Best- And Worst-Case Scenarios: Intra-Cellular Therapies, Inc. (ITCI), Macy's, Inc. (M) - Post Analyst
It was last traded at $15.78 apiece. Intra-Cellular Therapies, Inc. (ITCI): Outperform Candidate With 80.61% Upside Potential. Intra-Cellular Therapies, Inc. is maintained at an average outperform rating by 8 stock analysts, and there are at least 16 ...
The SunTrust Banks, Inc. Reaffirms “Hold” Rating for Intra-Cellular Therapies Inc. (ITCI) - BangaloreWeekly
Intra-Cellular Therapies Inc. (NASDAQ:ITCI)'s stock had its “hold” rating restated by research analysts at SunTrust Banks, Inc. in a research report issued to clients and investors on Friday. They currently have a ... 828,691 shares of the company ...altro »
Ghost Tree Capital Increases Stake in Intra Cellular Therapies (Call) (ITCI); Intl Business Machines (IBM) Shares ... - BZ Weekly
The stock decreased 1.77% or $0.29 on October 13, reaching $16.09. About 547,969 shares traded. Intra-Cellular Therapies Inc (NASDAQ:ITCI) has declined 68.76% since October 14, 2016 and is downtrending. It has underperformed by 85.46% the S&P500 ...altro »
Stock to Buy: Intra-Cellular Therapies, Inc. (ITCI) - Street Observer (press release)
Intra-Cellular Therapies, Inc. (ITCI) stock price traded with surging change along with the volume 0.37 million shares on Monday trading session. Shares are trading price at $19.80 with move of 2.64%. The company's 3-months average volume stands at 0 ...